221 related articles for article (PubMed ID: 7717321)
1. Mucosal synthesis and release of prostaglandin E2 from activated eosinophils and macrophages in ulcerative colitis.
Raab Y; Sundberg C; Hällgren R; Knutson L; Gerdin B
Am J Gastroenterol; 1995 Apr; 90(4):614-20. PubMed ID: 7717321
[TBL] [Abstract][Full Text] [Related]
2. Increased intraluminal release of eosinophil granule proteins EPO, ECP, EPX, and cytokines in ulcerative colitis and proctitis in segmental perfusion.
Carlson M; Raab Y; Peterson C; Hällgren R; Venge P
Am J Gastroenterol; 1999 Jul; 94(7):1876-83. PubMed ID: 10406252
[TBL] [Abstract][Full Text] [Related]
3. Immunnohistological assessment of intestinal eosinophil activation in patients with eosinophilic gastroenteritis and inflammatory bowel disease.
Bischoff SC; Mayer J; Nguyen QT; Stolte M; Manns MP
Am J Gastroenterol; 1999 Dec; 94(12):3521-9. PubMed ID: 10606314
[TBL] [Abstract][Full Text] [Related]
4. Tissue levels of tumor necrosis factor-alpha correlates with grade of inflammation in untreated ulcerative colitis.
Olsen T; Goll R; Cui G; Husebekk A; Vonen B; Birketvedt GS; Florholmen J
Scand J Gastroenterol; 2007 Nov; 42(11):1312-20. PubMed ID: 17852866
[TBL] [Abstract][Full Text] [Related]
5. Activation of eosinophils in the pathophysiology of ulcerative colitis.
Makiyama K; Kanzaki S; Yamasaki K; Zea-Iriarte W; Tsuji Y
J Gastroenterol; 1995 Nov; 30 Suppl 8():64-9. PubMed ID: 8563894
[TBL] [Abstract][Full Text] [Related]
6. Neutrophil and eosinophil granule proteins as markers of response to local prednisolone treatment in distal ulcerative colitis and proctitis.
Sangfelt P; Carlson M; Thörn M; Lööf L; Raab Y
Am J Gastroenterol; 2001 Apr; 96(4):1085-90. PubMed ID: 11316151
[TBL] [Abstract][Full Text] [Related]
7. Fecal eosinophil granule-derived proteins reflect disease activity in inflammatory bowel disease.
Saitoh O; Kojima K; Sugi K; Matsuse R; Uchida K; Tabata K; Nakagawa K; Kayazawa M; Hirata I; Katsu K
Am J Gastroenterol; 1999 Dec; 94(12):3513-20. PubMed ID: 10606313
[TBL] [Abstract][Full Text] [Related]
8. Plasma and mucosal prostaglandin E2 as a surrogate marker of ulcerative colitis activity.
Wiercińska-Drapało A; Flisiak R; Prokopowicz D
Rocz Akad Med Bialymst; 2001; 46():60-8. PubMed ID: 11780581
[TBL] [Abstract][Full Text] [Related]
9. Increased interleukin-8 (IL-8) in rectal dialysate from patients with ulcerative colitis: evidence for a biological role for IL-8 in inflammation of the colon.
Keshavarzian A; Fusunyan RD; Jacyno M; Winship D; MacDermott RP; Sanderson IR
Am J Gastroenterol; 1999 Mar; 94(3):704-12. PubMed ID: 10086655
[TBL] [Abstract][Full Text] [Related]
10. Increased eosinophil infiltration and degranulation in colonic tissue from patients with collagenous colitis.
Levy AM; Yamazaki K; Van Keulen VP; Burgart LJ; Sandborn WJ; Phillips SF; Kephart GM; Gleich GJ; Leiferman KM
Am J Gastroenterol; 2001 May; 96(5):1522-8. PubMed ID: 11374693
[TBL] [Abstract][Full Text] [Related]
11. Eosinophil activation in ulcerative colitis: studies on mucosal release and localization of eosinophil granule constituents.
Raab Y; Fredens K; Gerdin B; Hällgren R
Dig Dis Sci; 1998 May; 43(5):1061-70. PubMed ID: 9590423
[TBL] [Abstract][Full Text] [Related]
12. Different regulation of eosinophil activity in Crohn's disease compared with ulcerative colitis.
Lampinen M; Backman M; Winqvist O; Rorsman F; Rönnblom A; Sangfelt P; Carlson M
J Leukoc Biol; 2008 Dec; 84(6):1392-9. PubMed ID: 18801925
[TBL] [Abstract][Full Text] [Related]
13. Mucosal and plasma prostaglandin E2 in ulcerative colitis.
Wiercinska-Drapalo A; Flisiak R; Prokopowicz D
Hepatogastroenterology; 1999; 46(28):2338-42. PubMed ID: 10521993
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of tumor necrosis factor-alpha messenger RNA in the intestinal mucosa of inflammatory bowel disease, particularly in patients with disease in the inactive phase.
Akazawa A; Sakaida I; Higaki S; Kubo Y; Uchida K; Okita K
J Gastroenterol; 2002; 37(5):345-53. PubMed ID: 12051533
[TBL] [Abstract][Full Text] [Related]
15. The increased expression of an array of C-X-C and C-C chemokines in the colonic mucosa of patients with ulcerative colitis: regulation by corticosteroids.
Yang SK; Choi MS; Kim OH; Myung SJ; Jung HY; Hong WS; Kim JH; Min YI
Am J Gastroenterol; 2002 Jan; 97(1):126-32. PubMed ID: 11808935
[TBL] [Abstract][Full Text] [Related]
16. Rectal substance P concentrations are increased in ulcerative colitis but not in Crohn's disease.
Bernstein CN; Robert ME; Eysselein VE
Am J Gastroenterol; 1993 Jun; 88(6):908-13. PubMed ID: 7684884
[TBL] [Abstract][Full Text] [Related]
17. [Activation of nuclear factor-kappaB and effects of anti-inflammatory treatment thereon in intestinal mucosa of patients with ulcerative colitis].
Gan H; Ouyang Q; Chen Y; Xia Q
Zhonghua Yi Xue Za Zhi; 2002 Mar; 82(6):384-8. PubMed ID: 11953203
[TBL] [Abstract][Full Text] [Related]
18. Quantitative gene expression of cytokines in peripheral blood leukocytes stimulated in vitro: modulation by the anti-tumor nerosis factor-alpha antibody infliximab and comparison with the mucosal cytokine expression in patients with ulcerative colitis.
Moriconi F; Raddatz D; Ho NA; Yeruva S; Dudas J; Ramadori G
Transl Res; 2007 Oct; 150(4):223-32. PubMed ID: 17900510
[TBL] [Abstract][Full Text] [Related]
19. [Eosinophil activation by epithelial cells of the respiratory mucosa. Comparative study of normal mucosa and inflammatory mucosa].
Mullol J; Xaubet A; López E; Roca-Ferrer J; Carrión T; Roselló-Catafau J; Picado C
Med Clin (Barc); 1997 May; 109(1):6-11. PubMed ID: 9303983
[TBL] [Abstract][Full Text] [Related]
20. Colonic vasoactive intestinal polypeptide (VIP) in ulcerative colitis--a radioimmunoassay and immunohistochemical study.
Todorovic V; Janic B; Koko V; Micev M; Nikolic JA; Ratkovic M; Leposavic G; Jankovic T; Knezevic-Usaj S; Milicevic Z
Hepatogastroenterology; 1996; 43(9):483-8. PubMed ID: 8799381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
